601 related articles for article (PubMed ID: 6600260)
41. Murine lymphokine-activated killer (LAK) cells: phenotypic characterization of the precursor and effector cells.
Yang JC; Mulé JJ; Rosenberg SA
J Immunol; 1986 Jul; 137(2):715-22. PubMed ID: 2873187
[TBL] [Abstract][Full Text] [Related]
42. In vitro propagation and cloning of murine natural suppressor (NS) cells.
Hertel-Wulff B; Okada S; Oseroff A; Strober S
J Immunol; 1984 Nov; 133(5):2791-6. PubMed ID: 6237156
[TBL] [Abstract][Full Text] [Related]
43. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
[TBL] [Abstract][Full Text] [Related]
44. Identification of macromolecular insoluble cold globulin (MICG) as a new marker shared by NK and ADCC cells, but not expressed by NC cells.
Campos-Perera C; Murgita RA; Hauptman SP; Gronvik KO
Immunology; 1986 Sep; 59(1):101-7. PubMed ID: 2428732
[TBL] [Abstract][Full Text] [Related]
45. Precursor phenotype of lymphokine-activated killer cells in the mouse.
Salup RR; Mathieson BJ; Wiltrout RH
J Immunol; 1987 Jun; 138(11):3635-9. PubMed ID: 3108370
[TBL] [Abstract][Full Text] [Related]
46. Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.
Ronchese F; Collavo D; Zanovello P; Cerundolo V; Biasi G
Immunology; 1985 Feb; 54(2):265-74. PubMed ID: 2578429
[TBL] [Abstract][Full Text] [Related]
47. Adherent lymphokine-activated natural killer cells in normal and severe combined immunodeficiency mice: large granular lymphocytes with natural killer cell phenotype and high cytolytic activity.
Chang HL; Zaroukian MH; Morrison MH; Esselman WJ
Nat Immun Cell Growth Regul; 1989; 8(2):89-99. PubMed ID: 2788243
[TBL] [Abstract][Full Text] [Related]
48. Interleukin 2 is not sufficient for the continuous growth of cloned NK-like cytotoxic cell lines.
Olabuenaga SE; Brooks CG; Gillis S; Henney CS
J Immunol; 1983 Nov; 131(5):2386-91. PubMed ID: 6605387
[TBL] [Abstract][Full Text] [Related]
49. Interleukin 3 is a major negative regulator of the generation of natural killer cells from bone marrow precursors.
Kalland T
J Immunol; 1986 Oct; 137(7):2268-71. PubMed ID: 2876040
[TBL] [Abstract][Full Text] [Related]
50. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype.
Welsh RM; Haspel MV; Parker DC; Holmes KV
J Immunol; 1986 Feb; 136(4):1454-60. PubMed ID: 3003199
[TBL] [Abstract][Full Text] [Related]
51. Costimulatory signals are required for optimal proliferation of human natural killer cells.
Robertson MJ; Manley TJ; Donahue C; Levine H; Ritz J
J Immunol; 1993 Mar; 150(5):1705-14. PubMed ID: 7679691
[TBL] [Abstract][Full Text] [Related]
52. Overnight incubation of mouse spleen cells in recombinant IL-2 generates cytotoxic cells with NK characteristics from precursors enriched with or devoid of LGL.
Punturieri A; Velotti F; Piccoli M; Herberman RB; Frati L; Santoni A
Clin Exp Immunol; 1989 Jan; 75(1):155-60. PubMed ID: 2495199
[TBL] [Abstract][Full Text] [Related]
53. Cloning of murine splenic T lymphocytes and natural killer (NK) cells on filter paper discs: detection of a novel NK/T phenotype.
Sarzotti M; Kumar V; Bennett M; Kelsoe G
Eur J Immunol; 1991 Mar; 21(3):635-41. PubMed ID: 1672644
[TBL] [Abstract][Full Text] [Related]
54. Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice.
Yang H; Yogeeswaran G; Bukowski JF; Welsh RM
Nat Immun Cell Growth Regul; 1985; 4(1):21-39. PubMed ID: 3875791
[TBL] [Abstract][Full Text] [Related]
55. Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor.
Kasahara T; Djeu JY; Dougherty SF; Oppenheim JJ
J Immunol; 1983 Nov; 131(5):2379-85. PubMed ID: 6195261
[TBL] [Abstract][Full Text] [Related]
56. Phenotypic and functional characterization of long-lived NK cell lines of different maturational status obtained from mouse fetal liver.
Manoussaka M; Georgiou A; Rossiter B; Shrestha S; Toomey JA; Sivakumar PV; Bennett M; Kumar V; Brooks CG
J Immunol; 1997 Jan; 158(1):112-9. PubMed ID: 8977181
[TBL] [Abstract][Full Text] [Related]
57. Interleukin 2-dependent natural killer (NK) cell lines from patients with primary T cell immunodeficiencies.
Flomenberg N; Welte K; Mertelsmann R; O'Reilly R; Dupont B
J Immunol; 1983 Jun; 130(6):2635-43. PubMed ID: 6222110
[TBL] [Abstract][Full Text] [Related]
58. Production of B cell growth factor by a Leu-7+, OKM1+ non-T cell with the features of large granular lymphocytes (LGL).
Pistoia V; Cozzolino F; Torcia M; Castigli E; Ferrarini M
J Immunol; 1985 May; 134(5):3179-84. PubMed ID: 3920315
[TBL] [Abstract][Full Text] [Related]
59. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.
Luger TA; Uchida A; Köck A; Colot M; Micksche M
J Immunol; 1985 Apr; 134(4):2477-83. PubMed ID: 3882831
[TBL] [Abstract][Full Text] [Related]
60. Lymphokine-activated killer (LAK) cells. II. Delineation of distinct murine LAK-precursor subpopulations.
Ballas ZK; Rasmussen W; van Otegham JK
J Immunol; 1987 Mar; 138(5):1647-52. PubMed ID: 2879870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
